Cargando…
Recent revelations and future directions using single-cell technologies in chronic lymphocytic leukemia
Chronic lymphocytic leukemia (CLL) is a clinically and biologically heterogeneous disease with varying outcomes. In the last decade, the application of next-generation sequencing technologies has allowed extensive mapping of disease-specific genomic, epigenomic, immunogenetic, and transcriptomic sig...
Autores principales: | Oder, Blaž, Chatzidimitriou, Anastasia, Langerak, Anton W., Rosenquist, Richard, Österholm, Cecilia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117666/ https://www.ncbi.nlm.nih.gov/pubmed/37091144 http://dx.doi.org/10.3389/fonc.2023.1143811 |
Ejemplares similares
-
Editorial: The promise of immunogenetics for precision oncology
por: Vlachonikola, Elisavet, et al.
Publicado: (2023) -
T cell receptor gene repertoire profiles in subgroups of patients with chronic lymphocytic leukemia bearing distinct genomic aberrations
por: Vlachonikola, Elisavet, et al.
Publicado: (2023) -
Precision diagnostics in chronic lymphocytic leukemia: Past, present and future
por: Mollstedt, John, et al.
Publicado: (2023) -
Immunoglobulin gene analysis in chronic lymphocytic leukemia in the era of next generation sequencing
por: Davi, Frédéric, et al.
Publicado: (2020) -
Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL
por: Agathangelidis, Andreas, et al.
Publicado: (2022)